Appropriate follow-up interval of thin section CT scan for evaluating pure ground glass opacities of 10 mm or less in the lung field

Japanese Journal of Lung Cancer

Volumn 47, Issue 1, 2007, Pages 27-35

  Hiramatsu, Miyako ^a,b,c   Inagaki, Takuya ^a,c   Inagaki, Tomoya ^a   Matsui, Yoshio ^a   Satoh, Yukitoshi ^a,b,d   Okumura, Sakae ^a   Ishikawa, Yuichi ^b   Nakagawa, Ken ^a  

^a Cancer Institute Hospital   (Japan)

^b CANCER INSTITUTE   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Follow up; Ground glass opacity (GGO); Lung; Thin section CT (TSCT)

Indexed keywords

GLASS;

ANAMNESIS; ARTICLE; CANCER SURGERY; CIGARETTE SMOKING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; SMOKING HABIT;

EID: 34247224194     PISSN: 03869628     EISSN: None     Source Type: Journal    
DOI: 10.2482/haigan.47.27     Document Type: Article

References (19)

1. Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology. 1996;200:327-331.
2. Collins J, Stern EJ. Ground-glass opacity at CT: the ABCs. AJR Am J Roentgenol. 1997;169:355-367.
3. Nakajima R, Yokose T, Kakinuma R, et al. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002;26:323-329.
4. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest. 2002;121: 1464-1467.
5. Jang HJ, Lee KS, Kwon OJ, et al. Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign. Radiology. 1996;199:485-488.
6. Kushihashi T, Munechika H, Ri K, et al. Bronchioloalveolar adenoma of the lung: CT-pathologic correlation. Radiology. 1994;193:789-793.
7. Zwirewich CV, Vedal S, Miller RR, et al. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology. 1991;179:469-476.
8. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer. 1961;14:1272-1294.
9. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000;73:1252-1259.
10. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol. 2000;174:763-768.
11. Suzuki K, Asamura H, Kusumoto M, et al. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg. 2002;74:1635-1639.
12. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr. 2004;28:17-23.
13. http://www.thoracic-CT-screening.org/jpn/index.html
14. Japanese source
15. Suzuki K, Nagai K, Yoshida J, et al. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer. 1997;79:1521-1526.
16. Matsuzoe D, Hideshima T, Ohshima K, et al. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer. 1999;79: 1549-1552.
17. Japanese source
18. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients ? Ann Surg Oncol. 2003;10:972-992.
19. Brivio F, Lissoni P, Rovelli F, et al. Effects of IL-12 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline. Hepatogastroenterology. 2002;49: 385-387.